Increased temporal cortex CREB concentrations and antidepressant treatment in major depression - PubMed (original) (raw)
Comparative Study
Increased temporal cortex CREB concentrations and antidepressant treatment in major depression
D Dowlatshahi et al. Lancet. 1998.
No abstract available
Similar articles
- Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder.
Yamada S, Yamamoto M, Ozawa H, Riederer P, Saito T. Yamada S, et al. J Neural Transm (Vienna). 2003 Jun;110(6):671-80. doi: 10.1007/s00702-002-0810-8. J Neural Transm (Vienna). 2003. PMID: 12768362 - Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression.
Glantz LA, Gilmore JH, Overstreet DH, Salimi K, Lieberman JA, Jarskog LF. Glantz LA, et al. Schizophr Res. 2010 May;118(1-3):292-9. doi: 10.1016/j.schres.2009.12.027. Epub 2010 Jan 13. Schizophr Res. 2010. PMID: 20067857 Free PMC article. - ATF2, a member of the CREB/ATF family of transcription factors, in chronic stress and consequent to antidepressant treatment: animal models and human post-mortem brains.
Laifenfeld D, Karry R, Grauer E, Klein E, Ben-Shachar D. Laifenfeld D, et al. Neuropsychopharmacology. 2004 Mar;29(3):589-97. doi: 10.1038/sj.npp.1300357. Neuropsychopharmacology. 2004. PMID: 14647483 - [New perspectives of the mechanism of action of antidepressants arised from genomic theory of depression].
Cereseto M, Ferrero A. Cereseto M, et al. Vertex. 2003 Mar-May;14(51):30-5. Vertex. 2003. PMID: 12690407 Review. Spanish. - Kynurenines: from the perspective of major psychiatric disorders.
Myint AM. Myint AM. FEBS J. 2012 Apr;279(8):1375-85. doi: 10.1111/j.1742-4658.2012.08551.x. Epub 2012 Mar 27. FEBS J. 2012. PMID: 22404766 Review.
Cited by
- Voxelwise quantification of (11)C-rolipram PET data: a comparison between model-based and data-driven methods.
Rizzo G, Veronese M, Zanotti-Fregonara P, Bertoldo A. Rizzo G, et al. J Cereb Blood Flow Metab. 2013 Jul;33(7):1032-40. doi: 10.1038/jcbfm.2013.43. Epub 2013 Mar 20. J Cereb Blood Flow Metab. 2013. PMID: 23512132 Free PMC article. - Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.
Gonul AS, Akdeniz F, Taneli F, Donat O, Eker C, Vahip S. Gonul AS, et al. Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):381-6. doi: 10.1007/s00406-005-0578-6. Epub 2005 Apr 6. Eur Arch Psychiatry Clin Neurosci. 2005. PMID: 15809771 - [New insights into the pathogenesis and pathophysiology of depression].
Schüle C, Baghai TC, Rupprecht R. Schüle C, et al. Nervenarzt. 2007 Nov;78 Suppl 3:531-47; quiz 548-9. doi: 10.1007/s00115-007-2370-5. Nervenarzt. 2007. PMID: 17960353 Review. German. - MicroRNA as therapeutic targets for treatment of depression.
Hansen KF, Obrietan K. Hansen KF, et al. Neuropsychiatr Dis Treat. 2013;9:1011-21. doi: 10.2147/NDT.S34811. Epub 2013 Jul 29. Neuropsychiatr Dis Treat. 2013. PMID: 23935365 Free PMC article. - An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022.
Crocetti L, Floresta G, Cilibrizzi A, Giovannoni MP. Crocetti L, et al. Molecules. 2022 Aug 4;27(15):4964. doi: 10.3390/molecules27154964. Molecules. 2022. PMID: 35956914 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources